Ceribell, Inc. (CBLL)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
CBLL Chart
People also search for
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
CeriBell NASDAQ: CBLL outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it continues to build its hospital customer base.
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings
Although the revenue and EPS for CeriBell, Inc. (CBLL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ceribell, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 44 | $900.14 | $803 | -$97.14 | -10.79% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 1,000 | $11,490 | $21,310 | $9,820 | 85.47% |
 Point72 Asset Management LP Point72 Asset Management LP | 96,251 | $1.79M | $2.25M | $460,514.72 | 25.8% |
 Joseph Castro Nuveen LLC | 58,795 | $1.1M | $1.13M | $30,814.53 | 2.79% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 3 | $54.99 | $53.07 | -$1.92 | -3.49% |
Ceribell, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Marie Thibault BTIG | 1,023.51 | $21,811.05 | $21,811.05 | - | - |
Ceribell, Inc. (CBLL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Ceribell, Inc. ever had a stock split?
Ceribell, Inc. Profile
| Health Care Technology Industry | Healthcare Sector | Xingjuan Chao CEO | NASDAQ (NGS) Exchange | 15678C102 CUSIP |
| US Country | 327 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
CeriBell, Inc. is a forward-thinking company that specializes in the creation of cutting-edge, AI-based point-of-care electroencephalography (EEG) technology, primarily designed for the detection and management of neurological conditions. Originally founded in 2014 under the name Brain Stethoscope, Inc., the company adopted its current name, CeriBell, Inc., in August 2015, marking a significant phase in its commitment to innovation in the medical technology arena. Positioned in Sunnyvale, California, CeriBell has focused its efforts on filling the void within the acute care setting, offering advanced solutions that cater to the previously unmet needs of patients suffering from neurological issues.
Products and Services
The CeriBell System: Developed as a novel, state-of-the-art, point-of-care EEG platform, the CeriBell System is designed to provide quick and efficient monitoring capabilities within acute care settings. This system stands out for its ability to deliver rapid diagnostics, which is crucial for the effective management and treatment of patients with neurological conditions. The incorporation of AI technologies within this platform underscores CeriBell’s commitment to pushing the boundaries of medical technology, aiming to offer smarter and more reliable diagnostic solutions.
EEG Disposable Headbands: As part of its product lineup, CeriBell offers disposable EEG headbands that are specifically engineered for ease of use and efficiency. These headbands are integral to the CeriBell System, ensuring that patients are monitored comfortably without the need for complex or time-consuming setup processes. Their disposable nature also highlights CeriBell’s attention to hygiene and patient safety, eliminating cross-contamination risks and encouraging the adoption of the system in various healthcare settings.
Pocket-Sized Battery-Operated Recorders: CeriBell's innovation streak extends to the development of compact, portable EEG recorders. These pocket-sized devices are battery-operated, emphasizing mobility and ease of use in various settings, including outpatient care or in environments where traditional EEG systems may be impractical. By making EEG technology more accessible and convenient, CeriBell aims to bridge the gap in neurological monitoring and care, enabling timely intervention and better patient outcomes.
